Mergers & Acquisitions - Mergers & Acquisitions, Nephrology and Hepatology


Popular Filters

Mariel Therapeutics to acquire Stryker's BMP-7 assets

Mariel Therapeutics to acquire Stryker's BMP-7 assets


US clinical-stage drug developer Mariel Therapeutics has entered into a definitive agreement to acquire…

Anti-Arthritics/RheumaticsMariel TherapeuticsMergers & AcquisitionsNephrology and HepatologyPharmaceuticalStryker Corp

Shire acquires Fibrotech for $75 million

Shire acquires Fibrotech for $75 million


Ireland-headquartered drugmaker Shire has acquired Australian biopharmaceutical company Fibrotech for…

AustraliaFibrotechFocal segmental glomerulosclerosisGlomerulosclerosisHead of research and developmentIrelandKidney diseasesMergers & AcquisitionsNephrology and HepatologyPharmaceuticalPhil VickersShire

Islet Sciences to acquire BHV Pharma along with diabetes and NASH products

Islet Sciences to acquire BHV Pharma along with diabetes and NASH products


US biotech firm Islet Sciences says it has signed a binding letter of intent to acquire Brighthaven Ventures…

BiotechnologyDiabetesIslet SciencesMergers & AcquisitionsNephrology and Hepatologyremogliflozin

Italy’s Gentium accepts $1 billion takeover offer from Jazz Pharma


Ireland-headquartered drugmaker Jazz Pharmaceuticals has entered into a definitive agreement to acquire…

defibrotideDefitelioGentiumItalyJazz PharmaceuticalsMergers & AcquisitionsNephrology and HepatologyPharmaceuticalRare diseases

Cytori licenses Asia-Pacific cardiovascular, renal and diabetes markets to Lorem Vascular for up to $531 million


San Diego, USA-based Cytori Therapeutics and China-headquartered Lorem Vascular have entered a partnership…

Asia-PacificBiotechnologyCardio-vascularCytori TherapeuticsDiabetesLicensingLorem VascularMergers & AcquisitionsNephrology and Hepatology

Ocera Thera and Tranzyme complete merger


US clinical-stage biopharma firm Ocera Therapeutics and Tranzyme (Nasdaq: TZYM) have completed their…

BiotechnologyMergers & AcquisitionsNephrology and HepatologyOcera TherapeuticsOCR-002Tranzyme

OPKO Health inks deal to acquire Cytochroma and two Ph III products


Privately-held Canadian company Cytochroma says that it has entered into a definitive agreement to be…

AlpharenCytochromaMergers & AcquisitionsNephrology and HepatologyOPKO HealthPharmaceuticalReplidea

Baxter to expand renal therapies range with $4 billion buy of Gambro


Confirming recent rumors and speculation, Baxter International (NYSE:BAX ) said yesterday it has entered…

Baxter InternationalGambroMergers & AcquisitionsNephrology and HepatologyPharmaceutical

Amgen and KPCB to create Atara Biotherapeutics; Banner Pharmacaps changes hands


The world's largest biotech firm Amgen (Nasdaq: AMGN) and venture capital group Kleiner Perkins Caufield…

AmgenAtara BiotherapeuticsBanner PharmacapsBiotechnologyLicensingMergers & AcquisitionsNephrology and HepatologyOncologyPatheonPharmaceuticalProduction

Amgen to snap up KAI Pharma for $315 million


In a second acquisition announced so far this year, global biotech leader Amgen (Nasdaq: AMGN) said yesterday…

AmgenBiotechnologyKAI PharmaceuticalsMergers & AcquisitionsNephrology and Hepatology

Back to top